All filters
E-Posters
Seroprevalence And Co-Infections HIV, HBV And HCV Among Clinic Attenders At Laquintinie Hospital In Douala, Cameroon
P. D. Djouela Djoulako
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Long-Acting Cabotegravir + Rilpivirine for HIV Treatment: FLAIR Week 96 Results
R. D'Amico Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Optimisation of First-Line Antiretroviral Therapy (ART) for Children Living with HIV in Uganda: Translation from policy to action
E. Magongo Reviews in Antiviral Therapy & Infectious Diseases 7, 2020  
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Dual therapy including dolutegravir plus boosted-darunavir ensures high rate of virological control and rare resistance selection at failure in heavily treatment experienced PLWH
D. Armenia Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Dual therapy with Dolutegravir plus Lamivudine in virologically suppressed patients
C. Valente Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Real-world effectiveness of elbasvir/grazoprevir in the treatment of patients with hepatitis C virus genotype 1a infection in Norway
R. Leiva Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV A1 or B Do Not Differentially Impact Cabotegravir In Vitro Potency or Durability
J. Jeffrey Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
HIV evolution in patients initiating antiretroviral therapy during primary infection
B. Abdi Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Molecular Epidemiology of the HIV-1 Infection in Cyprus (2017-2019): A Polyphyletic Infection with an Increasing Prevalence of Drug Resistance
L. Kostrikis Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
A changing of HIV-1 genetic diversity in Russia during the last two decades: increase of the recombinants prevalence
A. Antonova Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Phylogenetic analyses applied to the study of transmission variants in a HIV-1 positive couple
A. Bergna  Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Abstracts
Unexpected rising in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategies.
M. Alkhatib Reviews in Antiviral Therapy & Infectious Diseases 7, 2020
Presented at:
European Meeting on HIV & Hepatitis 2020
Videos
Session 6 - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Session 4 - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2019
Videos
Session 5 - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
HBV Cure Science 101 - ICE-HBV - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Session 2 - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Session 1 - Panel Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Opening Session - Discussion
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Videos
Management of HBV - Test & Treat Strategy - Hailemichael Desalegn
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020